As I’ve said numerous times, including in yesterday’s roundup, it is Supreme Court season both in Washington, DC and on LexBlog Network as our members have been on a tear when it comes to providing detailed analysis of major decisions. It’s impossible for me to accurately describe, so do go visit LXBN’s Supreme Court section for the full view. In the meantime, here’s two of the most interesting cases covered—ones we’ve been tracking all the way up through the circuit courts—and another trending topic on our network.
- There’s no way around it, Association for Molecular Pathology v. Myriad Genetics is absolutely a landmark case—one that could have a very huge bearing on scientific and healthcare research in our country. At dispute in the case is whether or not companies can patent human genes, and specifically in this case, genes that cause cancer. The Supreme Court heard oral arguments in the case on Monday, and as she’s done with this case at every level, Antoinette Konski provides excellent analysis on the Personalized Medicine Bulletin.